Skip to main content
. 2023 Mar 23;12(9):10990–11009. doi: 10.1002/cam4.5807

FIGURE 6.

FIGURE 6

Validation of nucleoporin 107 (NUP107) in liver cancer patients in Guangxi. (A) Representative immunohistochemistry (IHC) images showing in situ expression of NUP107 in hepatocellular carcinoma (HCC) and adjacent liver tissues. (B) Violin chart showing the immunostaining scores of NUP107 in HCC and adjacent liver tissues in the Guangxi cohort. (C) Diagnostic ROC curve of NUP107 for the Guangxi cohort. (D) Expression level of NUP107 in the different BCLC stages.